Across TCGA pan-cancer cohorts, LINC02612 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02612’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where LINC02612 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02612 is over-expressed in tumor, although a few such as CHOL and LIHC show the opposite, repressed pattern.

KIRP, CHOL, and LIHC are the cancer types where LINC02612 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02612 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.060	.004	8	view →
CHOL	All	All	−0.150	.001	2	view →
LIHC	Female	II,III,IV	−0.093	.003	2	view →
LUAD	All	All	+0.026	.011	2	view →
BRCA	All	III,IV	−0.025	.006	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC02612 RNA expression & survival · all LINC02612 data types